Translate Bio Reaches Analyst Target Price
February 09, 2021 at 10:36 AM EST
In recent trading, shares of Translate Bio Inc (TBIO) have crossed above the average analyst 12-month target price of $34.17, changing hands for $34.33/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..